JP3301100008
JP3301100008
KOBAYASHI PHARMACEUTICALS
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 165.742.000.000 | 165.600.000.000 | 0.1% |
| Cost of Revenue | 81.030.000.000 | 77.997.000.000 | 3.9% |
| Gross Profit | 84.711.000.000 | 87.603.000.000 | 3.3% |
| 69.783.000.000 | 62.734.000.000 | 11.2% | |
| Operating Income | 14.928.000.000 | 24.869.000.000 | 40.0% |
| Pretax Income | 3.744.000.000 | 13.914.000.000 | 73.1% |
| Net Income Common Stockholders | 3.656.000.000 | 10.067.000.000 | 63.7% |
| -- | -- | -- | |
| -- | -- | -- |